arrow
A

Aleksandra Lesiak

medical university of lodz
H指数:30
被引数:4,339

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND

特应性皮炎中度至重度患者接受特立珠单抗治疗长达6年的长期安全性与有效性:开放标签扩展试验ECZTEND的最终结果

2026-02-050
OAAI
Immune Checkpoint Blockade Therapy for Advanced Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients, Transplant Recipients, and Individuals with Hereditary Syndromes: A Narrative Review

免疫检查点阻断疗法在免疫抑制患者、移植受者及遗传综合征个体中的晚期皮肤鳞状细胞癌治疗应用:一项叙述性综述

2025-11-180
OAAI
Sensitivity and Specificity of ELISA Tests Detecting BP180 and BP230 Antibodies in the Diagnosis of Bullous Pemphigoid: A Systematic Review and Meta-Analysis

ELISA检测BP180和BP230抗体的敏感性及特异性在 bullous pemphigoid 诊断中的应用:一项系统评价和Meta分析

2025-11-120
PRE
Impact of CARD14 rs34367357 Mutation, Nutrition Status, and Seasonality on the Response to Biologic Therapy in Psoriasis—A Retrospective Observational Single-Center Study

CARD14 rs34367357突变、营养状况和季节性对生物制剂治疗银屑病疗效的影响——一项回顾性观察性单中心研究

2025-10-010
OAAI
Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO-LT phase 3, open-label study

利特昔替尼在成人及青少年斑秃患者(头皮毛发损失至少25%)中的长期安全性与有效性:ALLEGRO-LT III期开放标签研究结果

2025-01-230
OAAI
Characteristics of Patients with Generalized Pustular Psoriasis: A Report of the Polish Generalized Pustular Psoriasis Group

泛发性脓疱型银屑病患者的特征: 波兰泛发性脓疱型银屑病组的报告

2024-11-211
OAAI
Exploring shared clinical features and successful therapeutic interventions in CARD14-associated papulosquamous eruption
2024-11-200
OA